MONTE ROSA THERAPEUTICS INC (GLUE) Stock Earnings Estimates
NASDAQ:GLUE • US61225M1027
18.98 USD
-0.18 (-0.94%)
At close: Feb 20, 2026
19.05 USD
+0.07 (+0.37%)
After Hours: 2/20/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75.622M | 139.16M 84.02% | 56.838M -59.16% | 66.334M 16.71% | 47.789M -27.96% | 72.444M 51.59% | 204.11M 181.75% | 692.43M 239.24% | 1.475B 113.02% | 2.217B 50.31% | |||
| EBITDA YoY % growth | -108.63M -53.54% | -137.089M -26.20% | -72.991M 46.76% | -41.82M 42.71% | 17.34M 141.46% | 108.12M 523.53% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.38M -54.20% | -143.311M -27.52% | -81.112M 43.40% | -34.827M 57.06% | -126.321M -262.71% | -150.099M -18.82% | -177.048M -17.95% | -226.894M -28.15% | -145.88M 35.71% | 314.56M 315.63% | 1.043B 231.57% | 1.74B 66.83% | |
| Operating Margin | N/A | N/A | -107.26% | -25.03% | -222.25% | -226.28% | -370.48% | -313.20% | -71.47% | 45.43% | 70.71% | 78.48% | |
| EPS YoY % growth | -2.29 20.50% | -2.64 -15.28% | -1.02 61.36% | -0.28 72.12% | -1.30 -357.03% | -1.61 -23.91% | -1.56 3.36% | -2.03 -30.28% | -1.10 45.67% | 3.77 442.59% | 11.05 192.84% | 17.08 54.55% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 -252.75% | -0.49 -186.63% | -0.50 -233.47% | -0.49 -47.19% | -0.47 -33.38% |
| Revenue Q2Q % growth | 15.816M -73.92% | 3.06M -96.40% | 3.315M -85.71% | 3.315M -74.04% | 3.392M -78.55% |
| EBITDA Q2Q % growth | -36.72M -273.82% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.239M -332.54% | -45.05M -202.30% | -49.47M -218.05% | -51.85M -57.24% | -51M -68.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.33 -13.79% | -0.38 | 0.05 | 13.20% |
| Q2 2025 Q2Q % growth | -0.15 65.12% | -0.39 | 0.24 | 61.87% |
| Q1 2025 Q2Q % growth | 0.56 205.66% | -0.34 | 0.90 | 262.91% |
| Q4 2024 Q2Q % growth | 0.23 139.66% | -0.02 | 0.25 | 1,080.39% |
| Q3 2024 Q2Q % growth | -0.29 58.57% | -0.50 | 0.21 | 41.55% |
| Q2 2024 Q2Q % growth | -0.43 39.44% | -0.55 | 0.12 | 21.93% |
| Q1 2024 Q2Q % growth | -0.53 18.46% | -0.58 | 0.05 | 9.30% |
| Q4 2023 Q2Q % growth | -0.58 7.94% | -0.34 | -0.24 | -69.89% |
| Q3 2023 Q2Q % growth | -0.70 -20.69% | -0.74 | 0.04 | 5.18% |
| Q2 2023 Q2Q % growth | -0.71 -24.56% | -0.71 | 0.00 | 0.56% |
| Q1 2023 Q2Q % growth | -0.65 -27.45% | -0.69 | 0.04 | 6.17% |
| Q4 2022 Q2Q % growth | -0.63 32.26% | -0.64 | 0.01 | 0.95% |
| Q3 2022 Q2Q % growth | -0.58 -34.88% | -0.61 | 0.03 | 5.21% |
| Q2 2022 Q2Q % growth | -0.57 84.30% | -0.55 | -0.02 | -3.39% |
| Q1 2022 Q2Q % growth | -0.51 | -0.53 | 0.02 | 4.21% |
| Q4 2021 Q2Q % growth | -0.93 | -0.51 | -0.42 | -82.96% |
| Q3 2021 Q2Q % growth | -0.43 | -0.45 | 0.02 | 4.62% |
| Q2 2021 Q2Q % growth | -3.63 | -0.41 | -3.22 | -784.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 12.768M 38.54% | 5.528M | 7.24M | 130.97% |
| Q2 2025 Q2Q % growth | 23.194M 394.01% | 11.016M | 12.178M | 110.55% |
| Q1 2025 Q2Q % growth | 84.929M 7,882.05% | 15.586M | 69.343M | 444.91% |
| Q4 2024 Q2Q % growth | 60.647M | 11.611M | 49.036M | 422.32% |
| Q3 2024 Q2Q % growth | 9.216M | 2.673M | 6.543M | 244.78% |
| Q2 2024 Q2Q % growth | 4.695M | 1.376M | 3.319M | 241.21% |
| Q1 2024 Q2Q % growth | 1.064M | 1.428M | -364K | -25.49% |
| Q4 2023 Q2Q % growth | 15.453M | -15.453M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.42% | -6.63% | -0.6% | 12.76% |
| Revenue | 0% | 0.93% | 0% | 10.23% |